abstract |
The present invention relates to inositol derivatives which are covalently used in the treatment or prevention of disorders associated with pathological calcium crystals such as cardiovascular calcification, nephrocalcinosis, cutaneous calcinosis, chondrocalcinosis and nephrolithiasis Modified with one, two or three solubility functional groups, especially polyethylene glycol moieties. |